Spyre Therapeutics (SYRE) Non-Current Deferred Tax Liability (2015 - 2017)

Spyre Therapeutics (SYRE) posted Non-Current Deferred Tax Liability of $63000.0 for Q4 2017, up 5.0% on a QoQ basis from $60000.0 in Q4 2016, and up 5.0% year-over-year from $60000.0 in Q4 2016.

Spyre Therapeutics (SYRE) Non-Current Deferred Tax Liability (2015 - 2017) Analysis & Trends

Spyre Therapeutics' Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $63000.0 for Q4 2017.

  • Quarterly Non-Current Deferred Tax Liability rose 5.0% year-over-year to $63000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $63000.0 (up 5.0% YoY) and the FY2017 annual result came in at $63000.0, up 5.0% from the prior year.
  • Non-Current Deferred Tax Liability was $63000.0 for Q4 2017 at Spyre Therapeutics, up from $60000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $63000.0 in Q4 2017 and bottomed at $49000.0 in Q4 2015.
  • A 3-year average of $57333.3 and a median of $60000.0 in 2016 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2016 — Non-Current Deferred Tax Liability increased 22.45% — and 2017, when it rose 5.0%.
  • Spyre Therapeutics' Non-Current Deferred Tax Liability stood at $49000.0 in 2015, then increased by 22.45% to $60000.0 in 2016, then climbed by 5.0% to $63000.0 in 2017.
  • Business Quant data shows SYRE's Non-Current Deferred Tax Liability at $63000.0 in Q4 2017, $60000.0 in Q4 2016, and $49000.0 in Q4 2015.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Spyre Therapeutics 257.83 Mn 257.83 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2017 63,000.00
Dec 31, 2017 63,000.00
Dec 31, 2016 60,000.00
Dec 31, 2016 60,000.00
Dec 31, 2015 49,000.00
Dec 31, 2015 49,000.00